Master of Biomedical Technology

About this programme

Through course and laboratory instruction plus a paid three-month Summer Practicum, students in the 12 month Master of Biomedical Technology program will be able to bridge from the academic to the corporate world. Students are exposed to a broad range of biotechnology and business concepts, along with cutting-edge technology. With mentorship and instruction from entrepreneurs, faculty, alumni and industry leaders, students acquire a tool kit of the technical and soft skills, knowledge and experience needed to directly enter a variety of career paths, including the pharmaceutical and biotechnology industries, along with biomedical, financial, regulatory or governmental careers. The MBT can be completed in combination with the course-based Master of Business Administration. Biotechnology, pharmaceuticals, start-ups, medical devices, clinical trials, regulatory affairs, sales and marketing, research and development, patent rights, licensing, project management, corporate leadership. A course-based master’s degree in biomedical technology is usually considered a final degree. See the Graduate Calendar for information on fees and fee regulations, and for information on awards and financial assistance . A minimum of 3.3 GPA on a 4.0 point system, over the past two years of full-time study (a minimum of 10 full-course equivalents or 60 units) of the undergraduate degree. A current C.V. A Vision Statement (no more than one page) outlining career goals and how the MBT program will help achieve them